Saybrook Capital’s Pfizer PFE Stock Holding History

Saybrook Capital’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$349K	Hold	14,500	–	–	0.09%	35
2026 Q1	$407K	Hold	14,500	–	–	0.11%	33
2025 Q4	$361K	Hold	14,500	–	–	0.09%	35
2025 Q3	$369K	Hold	14,500	–	–	0.1%	36
2025 Q2	$351K	Hold	14,500	–	–	0.1%	36
2025 Q1	$367K	Hold	14,500	–	–	0.1%	36
2024 Q4	$385K	Hold	14,500	–	–	0.1%	37
2024 Q3	$420K	Sell	14,500 -935	-6%	-$27.3K	0.12%	35
2024 Q2	$432K	Sell	15,435 -11,500	-43%	-$317K	0.12%	37
2024 Q1	$747K	Hold	26,935	–	–	0.2%	36
2023 Q4	$775K	Hold	26,935	–	–	0.22%	31
2023 Q3	$893K	Hold	26,935	–	–	0.27%	27
2023 Q2	$988K	Hold	26,935	–	–	0.29%	26
2023 Q1	$1.1M	Hold	26,935	–	–	0.35%	26
2022 Q4	$1.38M	Hold	26,935	–	–	0.46%	25
2022 Q3	$1.18M	Hold	26,935	–	–	0.42%	25
2022 Q2	$1.41M	Hold	26,935	–	–	0.46%	27
2022 Q1	$1.39M	Hold	26,935	–	–	0.38%	26
2021 Q4	$1.59M	Sell	26,935 -1,000	-4%	-$49.5K	0.4%	26
2021 Q3	$1.2M	Hold	27,935	–	–	0.33%	28
2021 Q2	$1.09M	Hold	27,935	–	–	0.3%	29
2021 Q1	$1.01M	Hold	27,935	–	–	0.31%	28
2020 Q4	$1.03M	Sell	27,935 -3,616	-11%	-$133K	0.33%	27
2020 Q3	$1.1M	Hold	31,551	–	–	0.39%	25
2020 Q2	$979K	Sell	31,551 -5,481	-15%	-$186K	0.39%	25
2020 Q1	$1.15M	Hold	37,032	–	–	0.53%	26
2019 Q4	$1.38M	Hold	37,032	–	–	0.54%	27
2019 Q3	$1.26M	Hold	37,032	–	–	0.53%	26
2019 Q2	$1.52M	Hold	37,032	–	–	0.64%	26
2019 Q1	$1.49M	Sell	37,032 -2,108	-5%	-$84.4K	0.65%	27
2018 Q4	$1.62M	Sell	39,140 -487	-1%	-$20.2K	0.77%	27
2018 Q3	$1.66M	Hold	39,627	–	–	0.71%	27
2018 Q2	$1.36M	Hold	39,627	–	–	0.63%	29
2018 Q1	$1.33M	Hold	39,627	–	–	0.63%	30
2017 Q4	$1.36M	Hold	39,627	–	–	0.63%	32
2017 Q3	$1.34M	Sell	39,627 -155	-0.4%	-$4.98K	0.66%	31
2017 Q2	$1.27M	Hold	39,782	–	–	0.64%	32
2017 Q1	$1.29M	Buy	39,782 +985	+3%	+$31.1K	0.7%	30
2016 Q4	$1.2M	Sell	38,797 -421	-1%	-$12.9K	0.76%	29
2016 Q3	$1.26M	Hold	39,218	–	–	0.8%	28
2016 Q2	$1.31M	Hold	39,218	–	–	0.85%	28
2016 Q1	$1.1M	Buy	39,218 +155	+0.4%	+$4.43K	0.7%	28
2015 Q4	$1.2M	Hold	39,063	–	–	0.76%	29
2015 Q3	$1.16M	Hold	39,063	–	–	0.78%	30
2015 Q2	$1.24M	Hold	39,063	–	–	0.79%	28
2015 Q1	$1.29M	Hold	39,063	–	–	0.85%	27
2014 Q4	$1.15M	Hold	39,063	–	–	0.67%	30
2014 Q3	$1.1M	Hold	39,063	–	–	0.66%	29
2014 Q2	$1.1M	Hold	39,063	–	–	0.66%	30
2014 Q1	$1.19M	Hold	39,063	–	–	0.75%	29
2013 Q4	$1.14M	Buy	39,063 +421	+1%	+$12.3K	0.72%	31
2013 Q3	$1.05M	Hold	38,642	–	–	0.76%	30
2013 Q2	$1.03M	Buy	+38,642	New	+$1.07M	0.74%	32

Other funds holding PFE

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

SLAM

Swiss Life Asset Management Zurich $24.1B AUM 38.82% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

CWP

Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Saybrook Capital's PFE Position: Q2 2026 in Review

Saybrook Capital held its Pfizer (PFE) position steady in Q2 2026 at 14,500 shares worth $349K. The position accounts for 0.09% of the portfolio, ranked #35.

Saybrook Capital first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.66M in Q3 2018. 1,338 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Saybrook Capital held 14,500 shares of Pfizer worth $349K as of Q2 2026.
Saybrook Capital left its Pfizer share count unchanged in Q2 2026.
Pfizer made up 0.09% of Saybrook Capital's portfolio in Q2 2026, its #35 holding.
Saybrook Capital first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
Saybrook Capital's Pfizer position peaked at $1.66M in Q3 2018.
1,338 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Saybrook Capital's 13F filing for Q2 2026, filed 31 Jul 2026.